AFB Culture MGIT Test: Purpose, Normal Range and Price

Key facts about the Afb Culture test
Also Known As	AFB MGIT TB Culture Test, Mycobacterial Culture, BACTEC MGIT Culture
Sample Type	Sputum (early morning), BAL, CSF, tissue, or other clinical specimen
Fasting Required	No (mouth rinsing with plain water before sputum collection required)
Report Delivery	4 to 42 days depending on bacterial load
Age Group	Adults and Children
Gender	All
Test Type	Liquid Broth Mycobacterial Culture with Fluorescent Detection
Units	Qualitative: No Growth or Growth Detected

The AFB Culture MGIT test is a microbiological culture test that grows and detects Mycobacterium tuberculosis and other acid-fast bacilli from clinical specimens using the Mycobacteria Growth Indicator Tube system, widely referred to as MGIT. MGIT is a liquid broth-based culture technology that uses an oxygen-sensitive fluorescent compound embedded in the base of each tube to detect mycobacterial growth. As mycobacteria multiply within the broth, they consume dissolved oxygen, causing the fluorescent sensor to emit an increasingly bright signal that is detected automatically by the BACTEC MGIT 960 instrument, enabling highly sensitive and fully automated detection of mycobacterial growth typically within 4 to 13 days, compared to the 6 to 8 weeks required by conventional solid Lowenstein-Jensen culture medium. AFB Culture MGIT is considered the gold standard microbiological method for definitive confirmation of tuberculosis and other mycobacterial infections, offering the highest sensitivity of any TB diagnostic method including molecular tests such as GeneXpert and TB PCR. While molecular tests detect genetic material from both living and dead bacteria and may remain positive after successful treatment, MGIT culture detects only viable living organisms, making it indispensable for confirming active infection, distinguishing between viable and non-viable bacteria during treatment monitoring, and performing drug susceptibility testing on the actual live bacterial isolate recovered from the patient. India carries the world's highest tuberculosis burden and the MGIT culture system has been progressively rolled out across NABL-accredited reference laboratories under the National TB Elimination Programme as the preferred platform for culture confirmation and drug susceptibility testing. The test is performed on an appropriate clinical specimen collected by a trained healthcare professional.

Doctors prescribe an AFB Culture MGIT test in the following situations: Confirming tuberculosis diagnosis with the highest possible microbiological certainty in patients where clinical, radiological, and molecular findings are suspicious but not conclusive, and where definitive culture confirmation of viable Mycobacterium tuberculosis is required before committing to a prolonged multi-drug anti-TB treatment regimen. Performing drug susceptibility testing on the isolated mycobacterial strain to determine the full antibiogram including sensitivity or resistance to first-line drugs rifampicin, isoniazid, pyrazinamide, and ethambutol, and second-line drugs including fluoroquinolones and injectable agents, enabling construction of the most effective individualised treatment regimen. Investigating smear-negative pulmonary tuberculosis in patients with strong clinical and radiological suspicion of TB but repeatedly negative sputum smear microscopy and molecular tests, where the superior sensitivity of liquid culture detects viable mycobacteria in paucibacillary specimens where other methods have failed. Diagnosing non-tuberculous mycobacterial infections caused by organisms such as Mycobacterium avium complex, Mycobacterium kansasii, and Mycobacterium abscessus in immunocompromised patients and those with structural lung disease, where MGIT culture followed by species identification distinguishes these infections from TB and guides species-specific antibiotic management. Monitoring treatment response in drug-resistant TB patients where serial MGIT culture during treatment tracks bacteriological clearance, confirms sputum conversion from culture-positive to culture-negative, and provides the most reliable evidence of treatment efficacy beyond symptomatic and radiological improvement. Investigating treatment failure and relapse in patients who have completed anti-TB therapy and present with recurrent disease where MGIT culture of new specimens confirms whether viable bacteria are present and whether drug resistance has evolved during prior treatment, guiding retreatment regimen design.

The AFB Culture MGIT test detects the presence or absence of viable acid-fast bacilli through liquid culture growth and reports results qualitatively. When growth is detected, further identification and drug susceptibility testing are performed on the recovered isolate. No Growth Detected A no growth result after the standard incubation period of up to six weeks indicates that no viable acid-fast bacilli were recovered from the tested specimen. This is a highly reassuring finding in a patient with clinical suspicion of TB, though a single negative culture does not entirely exclude TB in paucibacillary disease, and repeat culture of additional specimens may be recommended by the treating physician in high-suspicion cases. Growth Detected, Mycobacterium Tuberculosis Complex Detection of Mycobacterium tuberculosis complex confirms active TB infection with the presence of viable organisms in the tested specimen. This finding triggers automatic drug susceptibility testing on the recovered isolate to determine the full antibiogram, the results of which are reported alongside the culture result and form the basis for definitive treatment regimen selection under specialist TB care. Growth Detected, Non-Tuberculous Mycobacteria Detection of non-tuberculous mycobacteria indicates a mycobacterial infection that is not caused by the TB complex and requires species identification to determine clinical significance and appropriate management. NTM infections require entirely different antibiotic regimens from TB and their management should be guided by species identification results and species-specific drug susceptibility patterns under specialist infectious disease or pulmonology guidance.

The AFB Culture MGIT test is most commonly performed on an early morning sputum specimen, and specimen quality is the single most important determinant of culture sensitivity and reliability. Patients should collect a deep cough sputum specimen early in the morning before eating, drinking, or using any oral hygiene products, as early morning sputum has the highest concentration of mycobacteria and yields the best culture results for both detection and drug susceptibility testing. Before providing the sputum sample, rinse your mouth thoroughly with plain water only, strictly avoiding toothpaste, mouthwash, and antiseptic oral rinses immediately before collection, as antimicrobial compounds in these products can inhibit mycobacterial growth in culture and produce false negative results that delay the diagnosis. Collect the specimen in the sterile container provided by the laboratory, ensuring it contains genuine lower respiratory tract sputum rather than saliva. Inform your doctor if you are already receiving anti-TB medications before the test, as ongoing antibiotic therapy significantly reduces viable bacterial load and may produce false negative culture results or delayed growth. Rapid specimen transport to the laboratory is critical for MGIT culture as prolonged delays at room temperature can allow overgrowth of contaminating bacteria that inhibit mycobacterial growth. Specimens should be transported at 2 to 8 degrees Celsius if any delay is anticipated, and the laboratory should be notified in advance to ensure culture media are prepared and ready for immediate inoculation on specimen arrival.

If you are booking through the SecondMedic platform the AFB Culture MGIT test price starts at approximately Rs. 1529. The exact price will be confirmed at the time of booking through SecondMedic. If your doctor has prescribed multiple tests alongside AFB Culture MGIT, SecondMedic health packages include AFB Culture MGIT as part of a broader TB diagnostic panel at a significantly lower combined price.

SecondMedic offers convenient home sample collection for the AFB Culture MGIT test across India, making it easy to get tested without visiting a diagnostic centre. Home collection is available free of charge for orders above Rs. 300. A trained professional will visit your preferred address between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Your sample is processed at NABL-accredited partner laboratories, and your report is delivered as soon as results are available directly to your WhatsApp and email.